TransMedics climbs on Q4 revenue beat

TransMedics

28/02/2025 12:35

** Medical equipment maker TransMedics' TMDX.O shares rise 4.4% to $75 premarket

** Co's Q4 revenue of $121.6 million beats analysts' average expectation of $110.3 million, according to data compiled by LSEG

** TMDX forecasts annual revenue between $530 mln and $552 mln, the midpoint of which is above analysts' average estimate of $539 mln - LSEG

** Up to last close, stock down 18.7% in the last 12 months

 (Reporting by Christy Santhosh)

 ((Christy.Santhosh@thomsonreuters.com))